The Success of Innovacare Health under the leadership of Penelope Kokkinides

InnovaCare Inc is a leading Medicare and Medicaid organization that is specialized in offering healthcare-related services to its clients in Puerto Rico. The organization boasts of a membership of more than 200 000 people that are served by a well-established network with over 7, 500 providers. Besides providing healthcare solutions, the company is also in charge of managing two of Puerto Rico’s government health plans in a well-coordinated and benefit-oriented care model. It is the sole provider of NCQA-accredited solutions in the island and is fully committed to upholding utmost quality in the provision of healthcare through innovative, sustainable and managed care models that are not only affordable but also well-coordinated and integrated with state of the art technologies.

 

Leadership at InnovaCare Health

 

At the core of its management is a team of skilled and experienced professionals. The three recent leadership additions have channeled into the company a set of unique skill and rich background. The company is therefore well-equipped and staffed to further its objectives and remain afloat in the dynamic and unpredictable healthcare landscape.

 

As the C.E.O, Penelope Kokkinides prides herself on more than ten years’ experience in the realm of healthcare with a specialty in government programs. She has gained vast expertise and prowess in the management of healthcare practices and the development of clinical programs. In her tenure as the Chief Executive Officer, Penelope aims at focusing on improving organizational infrastructure and efficacy.

 

The recent appointment of Mike Sortino as the Chief Accounting Officer was also well-received. Mike was serving previously as the controller with Samsung Fire and Marine Insurance company. Before joining Samsung, Mike had served as the C.E.O of HCC Specialty. He has more than 20 years of experience in the field of insurance and reinsurance and a further 5 years as a public accountant.

 

Penelope Kokkinide meets President Donald Trump

 

Kokkinide recently attended a meeting held at the White House to discuss the health care of Puerto Rico with President Donald Trump alongside Seema Verma, the CMS administrator. The panel that was composed of women in the healthcare dates back on the 22nd of March 2018 was actually a round-table discussion that took place in the West Wing’s Roosevelt Room. During her speech, Kokkinide highlighted the need for increased funding for Puerto Rico’s Medicare Advantage. She acknowledged the drop in the financing of Medicare Advantage in Puerto Rico since the year 2011.

 

Jim Tananbaum Gigantic Investment Bets in the Health Sector

Jim Tananbaum, the founder, chief executive officer and managing director of Foresite Capital have welcomed Dr.Molly, a former senior director at Illumina, to the company as a venture partner. Foresite Company is San Francisco-based healthcare growth firm that aims at conducting extensive researches on medical and drugs breakthrough. This is done by providing capital and expertise to anchor public and private healthcare facilities to research and help their products get approved for use and sale to the public. More details can be found on Crunchbase.

Having a more than 25 years’ expertise in healthcare entrepreneurship and investment, Jim has acknowledged Dr.Molly as a precious asset to company’s breakthroughs. Having attained B.A in Biochemistry from Nankai University and a Ph.D. In protein biophysics from the University of California, Dr. Molly has vast experience in drug development and genomics. In addition, he had spent valuable years in the pharmaceutical industry and is an Author of various published medical work. You can visit LinkedIn to know more.

Holding a B.S.E.E from Yale University, an MD from Harvard Medical School, an MS from MIT and an MD and MBA from Harvard University, Jim Tananbaum, is a guru in healthcare investments. In his early career, he co-founded Prospect and Sierra Ventures where he helped instill investment practice in healthcare services. He attributes franchising to adopting strategic, operational and financial opportunities in the health care facilities. His major reputed led investments include Amira, Amerigroup, Jazz and Healtheon pharmaceuticals to mention a few. This has led to Jim ranked number 52 in Forbes magazine 2017 Mida List, of the 100 Top Tech Ventures Capital Investors, for the third consecutive year.

Despite founding Foresite in 2011, Jim Tananbaum also founded and headed Theravance Inc. and GelTex Pharmaceuticals, which brought two drugs to the market for less than $80 million and today they generate over $1 billion in revenue.  Its current investment companies include Orexigen, Therapeauticals Inc., Bio Delivery Sciences International Inc., among others. According to the stock market, Foresite has an approximate of $650 million worth of assets under its management. Visit Foresite Capital LinkedIn.

The 44 years old Manhattan-born billionaire, is also a Member of Yale’s University Council and the advisory committee of the Yale School of Engineering & Applied Science.

Check out his Facebook page